Clinical trial
Effects of Medisinstart for Type 2 Diabetes
NCT06273657 is registered in ClinicalTrials.gov with Apokus AS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Medisinstart for Type 2 Diabetes
- Lead sponsor
- Apokus AS
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 7, 2024
- Completion date
- February 28, 2026
- Enrollment
- 500 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes